Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nuvation Bio (NUVB) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $66.2 million.

  • Nuvation Bio's Operating Expenses rose 3992.98% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $247.5 million, marking a year-over-year decrease of 5571.32%. This contributed to the annual value of $593.4 million for FY2024, which is 49448.02% up from last year.
  • Per Nuvation Bio's latest filing, its Operating Expenses stood at $66.2 million for Q3 2025, which was up 3992.98% from $65.8 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Operating Expenses peaked at $470.5 million during Q2 2024, and registered a low of $20.2 million during Q1 2024.
  • Moreover, its 3-year median value for Operating Expenses was $47.3 million (2024), whereas its average is $80.5 million.
  • In the last 5 years, Nuvation Bio's Operating Expenses surged by 170044.01% in 2024 and then plummeted by 8600.43% in 2025.
  • Over the past 3 years, Nuvation Bio's Operating Expenses (Quarter) stood at $20.8 million in 2023, then soared by 166.13% to $55.4 million in 2024, then grew by 19.42% to $66.2 million in 2025.
  • Its Operating Expenses stands at $66.2 million for Q3 2025, versus $65.8 million for Q2 2025 and $60.0 million for Q1 2025.